Filing Details
- Accession Number:
- 0001062993-21-004868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-19 17:03:10
- Reporting Period:
- 2021-05-17
- Accepted Time:
- 2021-05-19 17:03:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Brickell Biotech Inc. | BBI | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1782334 | D Andrew Sklawer | C/O Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder CO 80301 | Coo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-17 | 15,375 | $0.80 | 124,625 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
